(QYLD) Global X NASDAQ 100 Covered - Ratings and Ratios

Exchange: NASDAQ • Country: USA • Currency: USD • Type: Etf • ISIN: US37954Y4834 • Derivative Income

QYLD: NASDAQ-100 Stocks, Covered Call Options

The Global X NASDAQ 100 Covered Call ETF (NASDAQ: QYLD) is designed to track the performance of the CBOE NASDAQ-100® BuyWrite Index. This index employs a buy-write (covered call) strategy, which involves holding a portfolio of stocks from the NASDAQ-100® Index while systematically selling (writing) one-month at-the-money NASDAQ-100® Index covered call options. The fund invests at least 80% of its total assets in the securities of the underlying index, providing exposure to the NASDAQ-100® stocks while generating income from option premiums. The ETF is non-diversified, meaning it can concentrate its holdings in a smaller number of securities.

As of the latest data, QYLD has an average trading volume of 9.3 million shares over the past 20 days, indicating moderate liquidity. The ETF is currently trading at $16.18, slightly above its 20-day simple moving average (SMA) of $16.00 but below its 50-day SMA of $16.74. The 200-day SMA stands at $16.81, suggesting a recent downtrend in price. The Average True Range (ATR) of 0.47 reflects relatively low volatility in recent trading sessions.

With total assets under management (AUM) of $8.096 billion, QYLD is a sizable ETF in its category. Its focus on the NASDAQ-100® Index, which includes 100 of the largest and most actively traded non-financial stocks on the NASDAQ, provides exposure to a mix of technology, consumer services, and biotechnology companies. The funds covered call strategy is designed to generate consistent income through option premiums, which can be attractive to investors seeking regular returns in a low-yield environment.

Over the next three months, based on , QYLD is expected to remain range-bound between $15.80 and $16.60, supported by its 50-day SMA at $16.74 and resistance at the 200-day SMA of $16.81. The low ATR of 0.47 suggests volatility will remain subdued, with minimal price fluctuations. From a perspective, the ETFs $8.096 billion in AUM indicates strong investor demand for its income-generating strategy, which should maintain liquidity and stability in the fund.

Additional Sources for QYLD ETF

QYLD ETF Overview

Market Cap in USD 8,096m
Category Derivative Income
TER 0.61%
IPO / Inception 2013-12-11

QYLD ETF Ratings

Growth Rating 59.1
Fundamental -
Dividend Rating 56.2
Rel. Strength -5.68
Analysts -
Fair Price Momentum 16.12 USD
Fair Price DCF -

QYLD Dividends

Dividend Yield 12m 13.71%
Yield on Cost 5y 20.81%
Annual Growth 5y -2.20%
Payout Consistency 91.8%

QYLD Growth Ratios

Growth Correlation 3m -88.8%
Growth Correlation 12m 61.8%
Growth Correlation 5y 71.8%
CAGR 5y 8.52%
CAGR/Max DD 5y 0.35
Sharpe Ratio 12m 1.21
Alpha -4.81
Beta 0.896
Volatility 23.32%
Current Volume 7673.4k
Average Volume 20d 9081.2k
What is the price of QYLD stocks?
As of May 01, 2025, the stock is trading at USD 16.30 with a total of 7,673,364 shares traded.
Over the past week, the price has changed by +1.56%, over one month by -0.97%, over three months by -9.13% and over the past year by +6.27%.
Is Global X NASDAQ 100 Covered a good stock to buy?
Partly, yes. Based on ValueRay Analyses, Global X NASDAQ 100 Covered (NASDAQ:QYLD) is currently (May 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 59.05 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of QYLD as of May 2025 is 16.12. This means that QYLD is currently overvalued and has a potential downside of -1.1%.
Is QYLD a buy, sell or hold?
Global X NASDAQ 100 Covered has no consensus analysts rating.
What are the forecast for QYLD stock price target?
According to ValueRays Forecast Model, QYLD Global X NASDAQ 100 Covered will be worth about 18.4 in May 2026. The stock is currently trading at 16.30. This means that the stock has a potential upside of +12.76%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 18.4 12.8%